PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Acamprosate calcium - Alcohol dependence
PAD Profile : Acamprosate calcium - Alcohol dependence
Keywords :
alcohol abstinence, abstinence from alcohol, alcohol dependency, alcohol abuse
Brand Names Include :
Campral EC
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
01 September 2021
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed the use of naltrexone and acamprosate for reducing alcohol consumption in people with alcohol dependence.
Naltrexone and acamprosate will be given a RED traffic light status, for prescribing by Drug and Alcohol teams only.
Any prescribing established in primary care prior to this decision may continue.
Associated BNF Codes
04. Central Nervous System
04.10.01. Alcohol dependence